Oral Montelukast and Cetirizine for Thyroid Eye Disease
暂无分享,去创建一个
[1] W. Bessler,et al. Stimulation of mast cells via FcεR1 and TLR2: The type of ligand determines the outcome , 2007 .
[2] W. Dawicki,et al. New and emerging roles for mast cells in host defence. , 2007, Current opinion in immunology.
[3] R. Keren,et al. Cochrane review: Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma , 2006 .
[4] Uri Alon,et al. The immune-body cytokine network defines a social architecture of cell interactions , 2006, Biology Direct.
[5] W. Calhoun,et al. The role of leukotrienes in airway inflammation. , 2006, The Journal of allergy and clinical immunology.
[6] D. Barbie,et al. Systemic mastocytosis: current classification and novel therapeutic options. , 2006, Clinical advances in hematology & oncology : H&O.
[7] J. Grainger,et al. Montelukast in allergic rhinitis: a systematic review and meta‐analysis , 2006, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[8] J. Boyce,et al. Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell. , 2006, The Journal of allergy and clinical immunology.
[9] A. Murakami,et al. Disodium Cromoglycate Inhibits Capsaicin-Induced Eosinophil Infiltration of Conjunctiva Independent of Mast Cells , 2006, Japanese Journal of Ophthalmology.
[10] S. Costagliola,et al. Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy , 2005, British Journal of Ophthalmology.
[11] W. Busse,et al. Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy. , 2005, Chest.
[12] M. Kaliner,et al. Cromolyn Sodium: Fitting an Old Friend into Current Asthma Treatment , 2005, The Journal of asthma : official journal of the Association for the Care of Asthma.
[13] D. de Benedictis,et al. Biological effects of montelukast, a cysteinyl‐leukotriene receptor‐antagonist, on T lymphocytes , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[14] P. Nigrovic,et al. Mast cells in inflammatory arthritis , 2004, Arthritis research & therapy.
[15] C. Bellas,et al. Differences in thyroid-infiltrating B lymphocytes in patients with Graves' disease: relationship to autoantibody detection. , 2004, Thyroid : official journal of the American Thyroid Association.
[16] J. Greif,et al. Effect of Montelukast, a Cysteinyl Receptor Antagonist, on Myofibroblasts in Interstitial Lung Disease , 2004, Journal of Clinical Immunology.
[17] D. Conen,et al. Montelukast and Churg-Strauss syndrome. , 2004, Swiss medical weekly.
[18] J. Abgrall,et al. Acquired thrombopathia related to montelukast therapy , 2004, Thrombosis and Haemostasis.
[19] S. Gangemi,et al. Montelukast-Induced Generalized Urticaria , 2004, The Annals of pharmacotherapy.
[20] C. Jackson,et al. Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis. , 2004, British journal of clinical pharmacology.
[21] M. Ludgate,et al. Inducing Graves’ ophthalmopathy , 2004, Journal of endocrinological investigation.
[22] J. Wall,et al. Eye muscle antibodies in Graves’ ophthalmopathy: Pathogenic or secondary epiphenomenon? , 2004, Journal of endocrinological investigation.
[23] Terry J. Smith. Novel aspects of orbital fibroblast pathology , 2004, Journal of endocrinological investigation.
[24] P. Kuna,et al. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation , 2004, Allergy.
[25] B. Lipworth,et al. Combined mediator antagonism for allergic rhinitis , 2004, Allergy.
[26] M. Ludgate. Animal models of thyroid-associated ophthalmopathy. , 2002, Thyroid : official journal of the American Thyroid Association.
[27] J. Wall,et al. Experimental Model for Ophthalmopathy in BALB/c and Outbred (CD-1) Mice Genetically Immunized with G2s and the Thyrotropin Receptor , 2002, Autoimmunity.
[28] G. Cockerham,et al. Clinicopathologic Evaluation of the Mueller Muscle in Thyroid-Associated Orbitopathy , 2002, Ophthalmic plastic and reconstructive surgery.
[29] W. Bessler,et al. Stimulation of mast cells via FcvarepsilonR1 and TLR2: the type of ligand determines the outcome. , 2007, Molecular immunology.
[30] M. Malice,et al. Onset of efficacy of montelukast in seasonal allergic rhinitis. , 2005, Allergy and asthma proceedings.
[31] A. Heufelder,et al. Retroocular fibroblasts: important effector cells in Graves' ophthalmopathy. , 1992, Thyroid : official journal of the American Thyroid Association.
[32] W. Cobbs,et al. Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease. , 1984, Ophthalmology (Rochester, Minn.).